<DOC>
	<DOCNO>NCT00645697</DOCNO>
	<brief_summary>One complication uveitis driven increase VEGF formation inflammatory ocular neovascularization ( ION ) . Here , analyze therapeutic role intravitreal bevacizumab ION respond standard therapy ( systemic ocular corticosteroid systemic immunosuppressant ) multicenter retrospective study.The natural history subfoveal choroidal new vessel histoplasmosis , multifocal choroiditis , Harada inflammatory chorioretinal disorder guard , new approach , hope stop visual loss relatively young patient .</brief_summary>
	<brief_title>Intravitreal Bevacizumab Recalcitrant Inflammatory Ocular Neovascularization</brief_title>
	<detailed_description>Members American Society Retinal specialist , American Uveitis Society International Uveitis Society invite contribute consecutive case ION respond standard therapy ( corticosteroid ( CST ) 4 immunosuppression ) treat intravitreal anti-VEGF agent . Cases concomitant prior cystoid macular edema , diabetes mellitus , age-related macular degeneration exclude . Most patient initially treat stepwise fashion high dos oral CST , without intraocular subtenon CST immunosuppressive therapy ( monitored rheumatologist ) . All patient opt intravitreal anti-VEGF treatment detail information limited experience , potential side effect off-label character drug . The risk benefit intravitreal therapy discuss patient ( guardian ) sign informed consent . Primary outcome measure : Best correct visual acuity measure logMAR . Secondary outcome measure : macular thickness OCT , stoppage leakage IVFA .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<mesh_term>Toxoplasmosis</mesh_term>
	<mesh_term>Choroiditis</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Inflammatory ocular neovascularization ( INO ) Eyes agerelated macular degeneration Diabetes mellitus Prior cystoid macular edema Uncontrolled systemic hypertension Cardiovascular disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>tuberculosis</keyword>
	<keyword>Multifocal serpiginous choroiditis</keyword>
	<keyword>histoplasmosis</keyword>
	<keyword>Harada toxoplasmosis</keyword>
</DOC>